Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. White, H. Nolte (Wheaton, Kenilworth, United States Of America). Characterisation of asthma flare ups. Eur Respir J 2009; 34: Suppl. 53, 1986

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Efficacy of CSJ117 on allergen-induced asthmatic responses in mild atopic asthma patients Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 From atopic dermatitis to asthma what drives the allergic march? Source: Eur Respir J 2003; 22: Suppl. 45, 137s Year: 2003 Evaluation of six-year allergen immunotherapy in allergic rhinitis and allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006 Refining asthma treatment for mild asthma Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 Characterisation of a chronic pre-clinical model of allergic asthma Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Inflammatory biomarkers in the evaluation of two-year  outcomes  of omalizumab treatment in severe allergic asthma. Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Predictors for asthma onset from cough variant asthma Source: Eur Respir J 2002; 20: Suppl. 38, 409s Year: 2002 Predicting exacerbations: asthma, allergy and exhaled NO Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 Cytokine profile in sputum from non-infective exacerbation of COPD and non-atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002 Utility of Interleukin-5 in phenotyping allergic versus non allergic asthma Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021 Identification of disease-specific molecular breath profiles in patients with allergic asthma Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020 Exacerbation of asthma Source: Annual Congress 2008 - Exacerbations of chronic respiratory disease – state of the art Year: 2008 Role of respiratory infection in exacerbations of atopic asthma Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Improved symptom relief with omalizumab in the treatment of allergic rhinitis Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Induced sputum in children with mild-to-moderate atopic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 143s Year: 2002 Age at onset and persistence of eczema and the subsequent risk of asthma and allergic rhinitis Source: Annual Congress 2012 - Environmental exposure and other risk factors for airway diseases Year: 2012 Continuing allergic inflammation determines asthma chronicity in children Source: Eur Respir J 2006; 28: Suppl. 50, 850s Year: 2006 Efficacy of omalizumab in patients with concomitant allergic asthma and atopic dermatitis: a pilot study Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 Inflammatory profile of patients with allergic asthma & rhinitis versus patients with allergic rhinitis alone Source: Annual Congress 2007 - Mechanisms of inflammation in asthma and rhinitis - from cell cultures to patients Year: 2007